NO972927D0 - 14<alfa>,17<alfa>-C2-broede 19-nor-progesteronderivater - Google Patents

14<alfa>,17<alfa>-C2-broede 19-nor-progesteronderivater

Info

Publication number
NO972927D0
NO972927D0 NO972927A NO972927A NO972927D0 NO 972927 D0 NO972927 D0 NO 972927D0 NO 972927 A NO972927 A NO 972927A NO 972927 A NO972927 A NO 972927A NO 972927 D0 NO972927 D0 NO 972927D0
Authority
NO
Norway
Prior art keywords
alfa
branded
progesterone derivatives
progesterone
derivatives
Prior art date
Application number
NO972927A
Other languages
English (en)
Other versions
NO310198B1 (no
NO972927L (no
Inventor
Klaus Schoellkopf
Wolfgang Halfbrodt
Joachim Kuhnke
Wolfgang Schwede
Karl-Heinrich Fritzemeier
Rolf Krattenmacher
Hans-Peter Muhn
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO972927D0 publication Critical patent/NO972927D0/no
Publication of NO972927L publication Critical patent/NO972927L/no
Publication of NO310198B1 publication Critical patent/NO310198B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO19972927A 1994-12-23 1997-06-23 19-norprogesteronderivater med 14<alfa>,17<beta>-C2-bro, farmasöytisk preparat og mellomprodukter for fremstilling avforbindelsene NO310198B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4447401A DE4447401A1 (de) 1994-12-23 1994-12-23 14,17-C¶2¶-überbrückte Steroide
PCT/EP1995/005107 WO1996020209A2 (de) 1994-12-23 1995-12-23 14α,17α-C2-ÜBERBRÜCKTE 19-NOR-PROGESTERONDERIVATE

Publications (3)

Publication Number Publication Date
NO972927D0 true NO972927D0 (no) 1997-06-23
NO972927L NO972927L (no) 1997-08-22
NO310198B1 NO310198B1 (no) 2001-06-05

Family

ID=6537601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972927A NO310198B1 (no) 1994-12-23 1997-06-23 19-norprogesteronderivater med 14<alfa>,17<beta>-C2-bro, farmasöytisk preparat og mellomprodukter for fremstilling avforbindelsene

Country Status (33)

Country Link
US (3) US5827842A (no)
EP (1) EP0799238B1 (no)
JP (1) JPH10511379A (no)
KR (1) KR100400621B1 (no)
CN (1) CN1109689C (no)
AR (1) AR002263A1 (no)
AT (1) ATE193300T1 (no)
AU (1) AU692346B2 (no)
BG (1) BG63274B1 (no)
CA (1) CA2208605C (no)
CZ (1) CZ292696B6 (no)
DE (2) DE4447401A1 (no)
DK (1) DK0799238T3 (no)
EE (1) EE03356B1 (no)
ES (1) ES2151612T3 (no)
FI (1) FI972624A (no)
GR (1) GR3034261T3 (no)
HU (1) HUP0600457A2 (no)
IL (1) IL116504A (no)
LT (1) LT4295B (no)
LV (1) LV11954B (no)
NO (1) NO310198B1 (no)
NZ (1) NZ298770A (no)
PL (1) PL182642B1 (no)
PT (1) PT799238E (no)
RO (1) RO119366B1 (no)
RU (1) RU2169153C2 (no)
SI (1) SI9520137A (no)
SK (1) SK282281B6 (no)
TW (1) TW333536B (no)
UA (1) UA45382C2 (no)
WO (1) WO1996020209A2 (no)
ZA (1) ZA9510923B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0931047A1 (en) * 1996-09-03 1999-07-28 The Trustees of Columbia University in the City of New York Intermediates for the synthesis of vitamin d and steroid derivatives and processes for preparation thereof
DE19848305C1 (de) * 1998-10-14 2000-05-25 Schering Ag Verfahren zur Umsetzung von substituierten Propargylalkoholen in Gegenwart von sauren Ionenaustauschern und Zwischenprodukte des Verfahrens
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
EP1216699A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628189A1 (de) 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE4326240A1 (de) 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Also Published As

Publication number Publication date
SK78897A3 (en) 1997-12-10
EE03356B1 (et) 2001-02-15
BG101554A (en) 1998-09-30
ZA9510923B (en) 1996-07-04
KR100400621B1 (ko) 2004-02-05
GR3034261T3 (en) 2000-12-29
AR002263A1 (es) 1998-03-11
PL320799A1 (en) 1997-10-27
TW333536B (en) 1998-06-11
US5973172A (en) 1999-10-26
PT799238E (pt) 2000-11-30
AU4433896A (en) 1996-07-19
RO119366B1 (ro) 2004-08-30
WO1996020209A3 (de) 1996-09-06
US5827842A (en) 1998-10-27
ES2151612T3 (es) 2001-01-01
MX9704774A (es) 1997-10-31
NZ298770A (en) 1999-10-28
BG63274B1 (bg) 2001-08-31
NO310198B1 (no) 2001-06-05
DE4447401A1 (de) 1996-07-04
WO1996020209A2 (de) 1996-07-04
CN1109689C (zh) 2003-05-28
CA2208605C (en) 2008-07-15
FI972624A0 (fi) 1997-06-18
PL182642B1 (pl) 2002-02-28
NO972927L (no) 1997-08-22
LV11954A (lv) 1998-01-20
CN1171115A (zh) 1998-01-21
IL116504A (en) 2001-11-25
IL116504A0 (en) 1996-03-31
CZ195497A3 (cs) 1998-03-18
CZ292696B6 (cs) 2003-11-12
LT97106A (en) 1997-10-27
LT4295B (lt) 1998-02-25
ATE193300T1 (de) 2000-06-15
DK0799238T3 (da) 2000-10-09
SK282281B6 (sk) 2002-01-07
FI972624A (fi) 1997-06-18
HUP0600457A2 (en) 2006-08-28
US6147065A (en) 2000-11-14
DE59508403D1 (de) 2000-06-29
EP0799238A2 (de) 1997-10-08
RU2169153C2 (ru) 2001-06-20
SI9520137A (sl) 1998-02-28
JPH10511379A (ja) 1998-11-04
LV11954B (lv) 1998-06-20
CA2208605A1 (en) 1996-07-04
AU692346B2 (en) 1998-06-04
UA45382C2 (uk) 2002-04-15
EP0799238B1 (de) 2000-05-24

Similar Documents

Publication Publication Date Title
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
FI953489A (fi) 2,6-diaminopuriinijohdannaisia
FI951772A (fi) 3,5-disubstituoidut tetrahydrofuran-2-onit
BR9506532A (pt) 1,2,3,4,-Tetraidro-5-Nitro-Pirimidinas substituidas
TR199800988A3 (tr) 5&#39; Deoksi-Sitidin türevleri.
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
DE69618634D1 (de) 1,4-benzodioxin-derivate
NO932842L (no) 1,4-benzodioksanderivater
DE59308564D1 (de) 2,4-Dialkyl-6-sec-alkylphenole
NO972927D0 (no) 14&lt;alfa&gt;,17&lt;alfa&gt;-C2-broede 19-nor-progesteronderivater
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
NO944024L (no) 1,2-dihydro-2-okso-pyridin
IT1295973B1 (it) Procedimento per l&#39;illuminazione di oggetti.
FR2724962B3 (fr) Tuile d&#39;avant-toit sous-faitiere.
FI923201A (fi) 3,4-dehyropiperidinderivat
NO942212D0 (no) 13,14-dihydro-PGF2
NO943791D0 (no) 1,2-dihydro-2-okso-3-metylsulfonylaminometylpyridin
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
ITMI941593A1 (it) Tetraidropiridine 3, 3-disostituite
IT1283187B1 (it) &#34;elettrovalvola.&#34;